PVH
62
4
ZION
52
3
NEE
44
3
AMGN
46
2
PRU
47
2
SO
51
3
AKAM
53
5
KR
50
4
CHRW
54
3
EOG
32
3
MSI
57
3
ETN
65
2
CMA
46
3
HCP
56
2
FIS
48
5
QRVO
20
2
SJM
21
2
AMT
33
3
LB
30
11
KIM
60
3
PVH
62
4
ZION
52
3
NEE
44
3
AMGN
46
2
PRU
47
2
SO
51
3
AKAM
53
5
KR
50
4
CHRW
54
3
EOG
32
3
MSI
57
3
ETN
65
2
CMA
46
3
HCP
56
2
FIS
48
5
QRVO
20
2
SJM
21
2
AMT
33
3
LB
30
11
KIM
60
3
Financhill
Back

The Oncology Institute 10K Form

Buy
61

TOI
The Oncology Institute

Last Price:
$0.27
Seasonality Move:
-6.55%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TOI News And Ratings

See the #1 stock for the next 7 days that we like better than TOI

TOI Financial Statistics

Sales & Book Value

Annual Sales: $324.2M
Cash Flow: $1.2M
Price / Cash Flow: 0
Annual Sales: $0.20
Price / Book: 1.09

Profitability

EPS (TTM): -0.78000
Net Income (TTM): $-70.2M
Gross Margin: $59.6M
Return on Equity: -163.45%
Return on Assets: -35.44%

The Oncology Institute Earnings Forecast

Key The Oncology Institute Financial Ratios

  • The Gross Profit Margin over the past 5 years for TOI is 18.37%.
  • The Selling, General & Administrative Expenses for TOI have been equal to 35.11% of Gross Profit Margin.
  • The Interest Expense is -8.16% of Operating Income.
  • The Net Earning history of TOI is -25.62% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

The Oncology Institute Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: TOI
Website: theoncologyinstitute.com

Debt

Debt-to-Equity Ratio: 5.91
Current Ratio: 2.49
Quick Ratio: 2.19

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TOI Technical Analysis vs Fundamental Analysis

Buy
61
The Oncology Institute (TOI) is a Buy

Is The Oncology Institute a Buy or a Sell?